Risk of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C virus infection in people with HIV

Journal:
Clinical Infectious Diseases
Published:
Affiliations:
32
Authors:
29
Institutions Authors Share
Harvard University, United States of America (USA)
5.500000
0.19
Bern University Hospital, Switzerland
2.000000
0.07
Italian Cohort Naive Antiretrovirals (ICONA), Italy
2.000000
0.07
Medical University of Innsbruck (MUI), Austria
2.000000
0.07
Boston Medical Center (BMC), United States of America (USA)
1.666667
0.06
Biomedical Research Networking Center for Infectious Diseases (CIBERINFEC), Spain
1.333333
0.05
Bordeaux Population Health (BPH), France
1.333333
0.05
McGill University Health Centre (MUHC), Canada
1.000000
0.03
McGill University, Canada
1.000000
0.03
University of Pennsylvania (Penn), United States of America (USA)
1.000000
0.03
London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom (UK)
1.000000
0.03
National and Kapodistrian University of Athens (UOA), Greece
1.000000
0.03
University General Hospital Attikon, Greece
1.000000
0.03
Boston University (BU), United States of America (USA)
0.833333
0.03
Stichting HIV Monitoring (SHM), Netherlands
0.666667
0.02
Amsterdam UMC, Netherlands
0.666667
0.02
Amsterdam Institute for Infection and Immunity and Infectious Diseases, Netherlands
0.666667
0.02
Investigación Sanitaria del Hospital Gregorio Marañón (IISGM), Spain
0.500000
0.02
Institute of Health Carlos III (ISCIII), Spain
0.500000
0.02
Southern Alberta Clinic (SAC), Canada
0.500000
0.02
University of Calgary (U of C), Canada
0.500000
0.02
National Institute for Health and Medical Research (INSERM), France
0.500000
0.02
University of Bordeaux, France
0.500000
0.02
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain
0.333333
0.01
Reial Academia de Medicina de Catalunya (RAMC), Spain
0.333333
0.01
Statistics In System biology and Translational Medicine (SISTM), France
0.333333
0.01
CHU de Bordeaux, France
0.333333
0.01